Literature DB >> 17714736

The regulatory effect of endogenous hydrogen sulfide on pulmonary vascular structure and gasotransmitters in rats with high pulmonary blood flow.

Xiaohui Li1, Junbao Du, Hongfang Jin, Xiuying Tang, Dingfang Bu, Chaoshu Tang.   

Abstract

The study aimed to explore the regulatory effect of endogenous hydrogen sulfide (H(2)S), a novel gasotransmitter, on pulmonary vascular structure and gasotransmitters in rats with high pulmonary blood flow. Thirty-two Sprague-Dawley rats were randomly divided into a sham group, shunt group, sham+PPG (propargylglycine, an inhibitor of cystathionine-gamma-lyase) group and shunt+PPG group. Rats in the shunt and shunt+PPG groups underwent abdominal aorta-inferior vena cava shunting. Rats in the shunt+PPG and sham+PPG groups were intraperitoneally injected with PPG. After 4 weeks of shunting, mean pulmonary artery pressure (MPAP) and pulmonary vascular structural remodeling (PVSR) were evaluated. H(2)S, nitric oxide (NO) and carbon monoxide (CO) contents were measured in lung tissues. Meanwhile, nitric oxide synthase (eNOS), heme oxygenase (HO-1) and proliferative cell nuclear antigen (PCNA) protein expressions and ERK activation were evaluated. After 4 weeks of shunting, rats showed PVSR with increased lung tissue H(2)S and NO content but decreased CO content. After the PPG treatment, MPAP further increased and PVSR was aggravated. Meanwhile, PCNA expression and ERK activation were augmented with decreased lung tissue CO and HO-1 protein production but increased lung tissue NO production and eNOS expression. H(2)S exerted a protective effect on PVSR, and the inhibition of the NO/NOS pathway and the augmentation of the CO/HO pathway might be involved in the mechanisms by which H(2)S regulates PVSR in rats with high pulmonary flow.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714736     DOI: 10.1016/j.lfs.2007.07.021

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Contribution of calcium-activated chloride channel to elevated pulmonary artery pressure in pulmonary arterial hypertension induced by high pulmonary blood flow.

Authors:  Kai Wang; Chuansi Chen; Jianfa Ma; Jinquan Lao; Yusheng Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice.

Authors:  Weihong Han; Zheng Dong; Christiana Dimitropoulou; Yunchao Su
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

3.  Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.

Authors:  Ya-Qian Huang; Hong-Fang Jin; Heng Zhang; Chao-Shu Tang; Jun-Bao Du
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  H(2)S inhibits oscillatory shear stress-induced monocyte binding to endothelial cells via nitric oxide production.

Authors:  Young-Mi Go; Hye-Rim Lee; Heonyong Park
Journal:  Mol Cells       Date:  2012-10-30       Impact factor: 5.034

5.  Changes in hydrogen sulfide in rats with hepatic cirrhosis in different stages.

Authors:  Ning Zhang; Yong Zheng; Wei-Gang Chen; Rui Li; Li-Xiu Song; Li-Hong Xu; Ke-Shu Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

Review 6.  Hydrogen sulfide and vascular regulation - An update.

Authors:  Boyang Lv; Selena Chen; Chaoshu Tang; Hongfang Jin; Junbao Du; Yaqian Huang
Journal:  J Adv Res       Date:  2020-05-16       Impact factor: 10.479

7.  Sulfhydration-associated phosphodiesterase 5A dimerization mediates vasorelaxant effect of hydrogen sulfide.

Authors:  Yan Sun; Yaqian Huang; Wen Yu; Siyao Chen; Qiuyu Yao; Chunyu Zhang; Dingfang Bu; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  Oncotarget       Date:  2017-05-09

8.  Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.

Authors:  Hui Zhang; Yanjun Lin; Yiwen Ma; Junfeng Zhang; Changqian Wang; Huili Zhang
Journal:  Int J Mol Med       Date:  2019-10-01       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.